TAILOR Trademark

Trademark Overview

On Friday, June 6, 2025, a trademark application was filed for TAILOR with the United States Patent and Trademark Office. The USPTO has given the TAILOR trademark a serial number of 99222386. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 6, 2025. This trademark is owned by Affini-T Therapeutics, Inc.. The TAILOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific study and research in the field(s) of cancer therapy, namely through the identification of T-cells targeting oncogenic driver peptides
tailor

General Information

Serial Number99222386
Word MarkTAILOR
Filing DateFriday, June 6, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, June 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific study and research in the field(s) of cancer therapy, namely through the identification of T-cells targeting oncogenic driver peptides

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 6, 2025
Primary Code042
First Use Anywhere DateTuesday, June 27, 2023
First Use In Commerce DateTuesday, June 27, 2023

Trademark Owner History

Party NameAffini-T Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Friday, June 6, 2025NEW APPLICATION ENTERED
Friday, June 6, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 6, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

tailor cells identification targeting oncogenic peptides driver through namely research study